Knight Therapeutics (KHTRF) News Today → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free KHTRF Stock Alerts $3.92 -0.10 (-2.49%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKnight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversityfinance.yahoo.com - March 28 at 12:05 PMKnight Therapeutics Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecastsfinance.yahoo.com - March 24 at 9:54 AMKnight Therapeutics Reports Fourth Quarter and Year-End 2023 Resultsglobenewswire.com - March 21 at 7:30 AMShort Interest in Knight Therapeutics Inc. (OTCMKTS:KHTRF) Drops By 8.1%americanbankingnews.com - March 18 at 6:16 AMKnight Therapeutics Inc.baystreet.ca - March 14 at 10:45 PMNotice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Callglobenewswire.com - March 14 at 7:30 AMKnight Therapeutics price target raised by C$0.50 at Raymond Jamesrealmoney.thestreet.com - March 6 at 9:05 PMKnight Therapeutics Inc. Celebrates its First Decade of Successglobenewswire.com - February 28 at 7:30 AMKnight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazilglobenewswire.com - February 21 at 5:30 PMKnight Therapeutics Inc.'s (TSE:GUD) top owners are retail investors with 43% stake, while 23% is held by private companiesfinance.yahoo.com - February 4 at 10:08 AMG2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN KNIGHT THERAPEUTICS INC.finance.yahoo.com - January 31 at 11:08 PMRBC Capital Keeps Their Buy Rating on Knight Therapeutics (KHTRF)markets.businessinsider.com - November 12 at 12:14 PMKnight Therapeutics: Strong Q3 Results and Positive Outlook Drive Buy Ratingmarkets.businessinsider.com - November 11 at 9:52 AMKnight Therapeutics reports Q3 resultsmsn.com - November 9 at 9:39 AMNotice of Knight Therapeutics' Third Quarter 2023 Results Conference Callfinance.yahoo.com - November 2 at 8:13 AMKnight Therapeutics (TSE:GUD) investors are sitting on a loss of 44% if they invested five years agofinance.yahoo.com - October 30 at 11:16 AMKnight Therapeutics Inc. ocupa el puesto 90 en la quinta clasificación anual de The Globe and Mail de Canada's Top Growing Companies.prnewswire.com - October 3 at 6:06 PMKnight Therapeutics Inc. ocupa a 90ª posição no quinto ranking anual das Empresas de Maior Crescimento do Canadá (Canada's Top Growing Companies) segundo a The Globe and Mail.prnewswire.com - October 3 at 6:06 PMExecutive Chairman of Knight Therapeutics Jonathan Goodman Buys More Stockfinance.yahoo.com - September 29 at 8:13 AMKnight Therapeutics (KHTRF) Receives a Hold from Stifel Nicolausmarkets.businessinsider.com - August 10 at 6:16 PMNotice of Knight Therapeutics’ Second Quarter 2023 Results Conference Callfinancialpost.com - August 3 at 8:40 PMAnalysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Knight Therapeutics (OtherKHTRF)markets.businessinsider.com - July 12 at 6:30 PMRBC Capital Sticks to Its Buy Rating for Knight Therapeutics (KHTRF)markets.businessinsider.com - May 15 at 11:22 PMKnight Therapeutics Reports First Quarter 2023 Resultsfinance.yahoo.com - May 11 at 7:36 AMKnight Therapeutics Inc. announces voting results from the Annual General Meetingfinance.yahoo.com - May 10 at 7:22 PMClosing Bell: Knight Therapeutics Inc flat on Tuesday (GUD)theglobeandmail.com - May 2 at 5:56 PMClosing Bell: Knight Therapeutics Inc down on Tuesday (GUD)theglobeandmail.com - April 25 at 6:47 PMA number of insiders bought Knight Therapeutics Inc. (TSE:GUD) stock last year, which is great news for shareholdersfinance.yahoo.com - April 17 at 2:16 PMClosing Bell: Knight Therapeutics Inc up on Thursday (GUD)theglobeandmail.com - April 7 at 12:38 PMBloom Burton Keeps Their Buy Rating on Knight Therapeutics (KHTRF)markets.businessinsider.com - March 26 at 9:58 AMRBC Capital Sticks to Their Buy Rating for Knight Therapeutics (KHTRF)markets.businessinsider.com - March 24 at 7:41 PMG2S2 CAPITAL INC. ANNOUNCES INVESTMENT IN KNIGHT THERAPEUTICS INC.finance.yahoo.com - March 24 at 12:00 AMStifel Nicolaus Remains a Hold on Knight Therapeutics (KHTRF)markets.businessinsider.com - March 23 at 6:59 PMBerkadia Forges Alliance With Knight Frankfinance.yahoo.com - January 26 at 3:35 PMKnight Therapeutics Closes $38.5 Mln Loan With International Finance Corp.marketwatch.com - December 23 at 12:40 PMKnight Therapeutics Closes US$38.5 million Loan with IFCfinance.yahoo.com - December 23 at 7:39 AMIs Ardelyx is A Buy After Slip in Early 2022 (KHTRF)marketbeat.com - November 21 at 1:45 PMKnight Therapeutics Inc. (KHTRF) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 13 at 3:41 PMKnight Therapeutics Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 12 at 11:28 AMKnight to Present at Stifel Healthcare Conferencefinance.yahoo.com - November 9 at 7:46 PMNotice of Knight Therapeutics' Third Quarter 2022 Results Conference Callfinance.yahoo.com - November 3 at 12:08 PMKnight Therapeutics' (KHTRF) CEO Samira Sakhia on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 12 at 4:24 PMG2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN KNIGHT THERAPEUTICS INC.benzinga.com - August 12 at 4:16 AMKnight Therapeutics To Relaunch AKYNZEO In Brazilnasdaq.com - July 4 at 4:06 PMDoes Knight Therapeutics (TSE:GUD) Have A Healthy Balance Sheet?finance.yahoo.com - June 14 at 9:04 AMKnight Therapeutics enters license, supply pacts with Rigelseekingalpha.com - May 24 at 11:11 AMKnight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi®finance.yahoo.com - May 12 at 7:24 AMKnight to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conferencebenzinga.com - April 25 at 6:28 PMKnight Therapeutics Inc. (TSE:GUD) insiders placed bullish bets worth CA$3.1m in the last 12 monthsfinance.yahoo.com - March 31 at 1:41 PMKnight Therapeutics reports Q4 resultsseekingalpha.com - March 25 at 10:22 PM Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address [BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it. Get the name of the stock here - before it takes off >>> KHTRF Media Mentions By Week KHTRF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KHTRF News Sentiment▼0.390.61▲Average Medical News Sentiment KHTRF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KHTRF Articles This Week▼30▲KHTRF Articles Average Week Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ABSCF News ACRDF News ACRHF News ALEAF News LBTSF News AZFL News ERBB News AVTBF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KHTRF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyInvestors Alert: The Next Big Thing in Weight LossBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.